Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Synthetic chemical offers solution for crops facing drought

04.05.2009
UC Riverside-led research team shows pyrabactin mimics hormone employed by plants when water is scarce

Crops and other plants are constantly confronted with adverse environmental conditions, lowering yield and costing farmers billions of dollars annually. Plants use specialized signals, called stress hormones, to sense difficult times and adapt to stressful conditions to enhance survival.

Of the various stress hormones, abscisic acid (ABA), produced naturally by plants, has emerged over the last 30 years as the key hormone that helps plants cope with drought conditions. Under such stress, plants increase their ABA levels, which helps them survive the drought through a process not fully understood. So critical is this endogenous chemical to plant survival that researchers have engineered new drought-resistant crops by tinkering with the ABA pathway.

For years, scientists have contemplated spraying ABA directly onto crops to enhance their protection in times of stress. But ABA is a costly, complicated and light-sensitive molecule that has not found use in agriculture.

Now new research from the laboratory of Sean Cutler, an assistant professor of plant cell biology in the Department of Botany and Plant Sciences at the University of California, Riverside, suggests the possibility of spraying stable synthetic chemicals on plants to enhance stress tolerance during times of drought and improve yield.

Using a method called chemical genomics, pioneered by UC Riverside researchers for studying plant biology, Cutler identified pyrabactin, a new synthetic chemical that turns on the ABA signaling pathway in Arabidopsis, a small flowering plant used widely in plant biology laboratories as a model organism.

His lab then used pyrabactin to fish out a receptor for ABA – a highly controversial topic involving retractions of scientific papers as well as the publication of papers of questionable significance. A receptor is a protein molecule in a cell to which mobile signaling molecules may attach. Usually at the top of a signaling pathway, it functions like a boss relaying orders to the team below that then executes particular decisions in the cell.

"Scientists have been trying to solve the ABA receptor problem for more than 20 years, and claims for ABA receptors are not easily received by the scientific community," said Cutler, who came to UCR in 2007 from the University of Toronto. "We screened thousands of chemicals for one that mimics ABA. We found pyrabactin activates some of the ABA receptors in plants and is an excellent mimic of ABA. Moreover, unlike ABA, it is stable and easy to make. It therefore suggests a highly effective chemical strategy for improving plants' ability to survive under low-water conditions, potentially benefiting farmers in drought-prone areas worldwide."

Cutler's approach highlights the power of the chemical genetic approach for uncovering new leads for agrichemistry and, in turn, using those leads to understand a biological process.

"This is a striking example of how a chemical allowed us to solve a problem that genetics has been struggling with," he said. "Clearly, chemical genetics can be used to bypass some of the limitations that slow down classical genetic analysis. Not too long ago, the United Nations called for a 'blue revolution' - the water equivalent of the green revolution - of improved water management and sharing. We have proven that we can enlist chemicals that modulate stress responses in crops as soldiers in the blue revolution. Now our goal is to design the best chemical soldiers possible."

Study results appear April 30 in Science Express and in the May 22 issue of Science magazine.

Because of the prior questionable data in the ABA field, Cutler, the research paper's lead author, took the unusual step of sharing his data with key competitors and turning them into collaborators before publishing the results. Several labs working in the ABA signaling field tested the ABA receptor that Cutler's group identified, and validated his results. Scientists from these labs are co-authors of the research paper.

"Several high-profile papers have tried to claim discovery of ABA receptors but their research could not stand the test of time, and these papers were ultimately withdrawn," said Natasha Raikhel, the director of UCR's Center for Plant Cell Biology, of which Cutler is a member. "I believe this time, Dr. Cutler and his team have isolated a true ABA receptor."

Next in the research, Cutler and collaborator Brian Volkman of the Medical College of Wisconsin will work on deducing the structure of receptor-bound ABA and use this information to guide the design of new chemicals that turn on the ABA signaling pathway. Cutler and collaborators also plan to further understand how the ABA receptors affect plant physiology.

Cutler was joined in the research by colleagues at UCR; the University of Toronto, Canada; UC San Diego; Universidad Politecnica, Spain; University of Ontario Institute of Technology, Canada; UC Santa Barbara; and the Medical College of Wisconsin.

Grants from the Canadian Research Chair, the Natural Sciences and Engineering Research Council (Canada), the National Science Foundation and the National Institutes of Health funded the five-year study.

The University of California, Riverside is a doctoral research university, a living laboratory for groundbreaking exploration of issues critical to Inland Southern California, the state and communities around the world. Reflecting California's diverse culture, UCR's enrollment of about 17,000 is expected to grow to 21,000 students by 2020. The campus is planning a medical school and has reached the heart of the Coachella Valley by way of the UCR Palm Desert Graduate Center. The campus has an annual statewide economic impact of more than $1 billion. To learn more, visit www.ucr.edu or call (951) UCR-NEWS.

Iqbal Pittalwala | EurekAlert!
Further information:
http://www.ucr.edu

More articles from Life Sciences:

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

nachricht The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>